Cofounder and CEO OmGeneum, ÉlpisÉremo, and ARMADYNE.. He has over 25 years expertise in pioneering research, development and clinical translation of cutting-edge cellular regenerative medicine technology. Established Japans first pluripotent stem cell company (Jimmy’s Invest-ment Group “JIG”) for his son, Jimmy. In 2000 partnered with RGI (Reproductive Genetics Institute). In 2004 Cofounded Asclepius Thera-peutics, a venture with Dr. Yury Verlinsky, and served as the CEO, to establish the world’s first patient-specific pluripotent somatic stem Cell reprogram-ming company. (STEMBRID).